Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hephaï is a French healthtech company specializing in the digital management of respiratory diseases such as asthma and COPD. The company has developed an AI-powered platform that utilizes computer vision via a smartphone camera to monitor and correct a patient's inhaler technique in real-time. By ensuring proper medication delivery, Hephaï aims to improve treatment efficacy, reduce exacerbations, and lower healthcare costs associated with respiratory conditions. The solution is designed for use by both patients at home and healthcare professionals in clinical settings to ensure adherence and correct usage. Their technology is compatible with various types of inhalers, making it a versatile tool for respiratory care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hephaï.